February Table of Contents

External Link - article-85018.pdf

Articles in this issue

over 22 years ago

Article

Upping the Ante

over 22 years ago

Article

Knowing When to Pull the Plug On Your Experimental Drug

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

February Table of Contents

Articles in this issue

Related Content

Pharmaceutical Executive Daily: Eli Lilly Acquires Engage Bio

Eli Lilly Enters $202 Million Agreement to Acquire Engage Bio

Targeting HPV’s Hidden Mechanism: Q&A with Sandra Coufal, MD

Pharma Roundup: Bristol Myers Squibb Enters Strategic Agreement with Anthropic, Incyte and Genesis Expand Strategic Collaboration

Positioning TGN-S15 as Synergistic With Keytruda in HPV-Induced Cancers

Trending on PharmExec

FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report

Pharma Roundup: Bristol Myers Squibb Enters Strategic Agreement with Anthropic, Incyte and Genesis Expand Strategic Collaboration

Eli Lilly Enters $202 Million Agreement to Acquire Engage Bio

Pharma Funding Roundup: Violet Therapeutics' $4.75 Million Seed Extension Financing, Full-Life Technologies Completes $150 Million Financing

The Industry’s Communication and Engagement with FDA